Repurposing antiparasitic N,N′‐aliphatic diamine derivatives as promising antimycobacterial agents
- 12 September 2024
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (11) , e2400597
Abstract
In previous studies, we demonstrated the potent activity of a library of 25 N,N′‐disubstituted diamines (NNDDA) toward Trypanosomatid and Apicomplexa parasites. Considering the structure similarity between this collection and SQ109, an antituberculosis compound, and its compelling antiparasitic properties, we aimed to repurpose this library for tuberculosis treatment. We assayed this collection against Mycobacterium tuberculosis H37Rv and M. avium, obtaining several compounds with MIC values below 10 µM. The most active analogs were also evaluated against M. smegmatis, a non‐pathogenic species, and the non‐tuberculosis mycobacteria M. abscessus, M. kansasii, and M. fortuitum. 3c stands out as the lead mycobacterial compound of the collection, with potent activity against M. tuberculosis (minimal inhibitory concentration [MIC] = 3.4 µM) and moderate activity against M. smegmatis, M. kansasii, and M. fortuitum (all with MIC values of 26.8 µM). To unravel the mechanism of action, we employed the web‐based platform Polypharmacology Browser 2 (PPB2), obtaining carbonic anhydrases as potential drug targets. Nevertheless, none of the compounds displayed experimental inhibition. In summary, our study confirms the validity of the repurposing approach and underscores the antimycobacterial potential of NNDDA compounds, especially the analog 3c, setting a stepping stone for further studies.Keywords
This publication has 33 references indexed in Scilit:
- New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazidEuropean Journal of Medicinal Chemistry, 2020
- Synthesis of pyrazinamide analogues and their antitubercular bioactivityMedicinal Chemistry Research, 2020
- Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium TuberculosisEuropean Journal of Medicinal Chemistry, 2020
- SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca2+ homeostasis, collapsing the mitochondrial electrochemical potential (ΔΨm) and affecting acidocalcisomesParasitology Research, 2020
- A minimalistic approach to develop new anti-apicomplexa polyamines analogsEuropean Journal of Medicinal Chemistry, 2018
- Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosisInfection, Genetics and Evolution, 2016
- Synthesis and antikinetoplastid activity of a series of N,N′-substituted diaminesBioorganic & Medicinal Chemistry Letters, 2012
- Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivativesEuropean Journal of Medicinal Chemistry, 2010
- Discovery of dipiperidines as new antitubercular agentsBioorganic & Medicinal Chemistry Letters, 2010
- emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutolInternational Journal of Medical Microbiology, 2009